HL Pharma attended the recent Operationalizing Early Access Programmes Summit. The European event provided an invaluable platform for addressing critical issues within the pharmaceutical industry.
read moreHL Pharma serves as the exclusive distributor of WomanCare Global’s Manual Aspiration Vacuum & Cannulas for Miscarriage in Australia.
read moreCPHI Barcelona Spain, at the epicentre of the pharmaceutical industry for over three decades and, the 2nd Operationalise Early Access Programmes Europe Summit.
read moreTick-Borne Encephalitis (TBE) is a viral infection that attacks the central nervous system and can result in serious meningitis, brain inflammation and in some instances death. Travellers who spend time in regions where TBE is endemic may be at risk. The highest risk is during the warmer months from April to November, especially when hiking…
read moreHundreds of thousands of Australians with life-threatening high cholesterol could benefit from a new pill in the pipeline, following the successful research and trial by Prof Stephen Nicholls, Director of the Victorian Heart Hospital and Victorian Heart Institute, based at the Monash University Clayton campus.
read moreThe Therapeutic Goods Administration (TGA) has issued 5 infringement notices totalling $13,320 to 3 health practitioners for the alleged unlawful importation of unregistered prescription-only medicines.
read moreHL Pharma is excited to announce Dr Paula Martin has joined the team, partnering on the WomanCare Global obstetric and gynaecological product range.
read moreFrom 1 July this year, medicines containing the psychedelic substances psilocybin and MDMA (3,4-methylenedioxy-methamphetamine) can be prescribed by specifically authorised psychiatrists for the treatment of certain mental health conditions through the Special Access Scheme.
read more
